C Bilhou-Nabéra - Concepedia

Author

C Bilhou-Nabéra

Hôpital Cardiologique du Haut-Lévêque

Also Known As

C Bilhou-Nabera, C Bilhou-Nabéra, C. Bilhou-Nabera, C. Bilhou-Nabéra, C. Bilhou‐Nabera

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Hôpital Cardiologique du Haut-Lévêque Centre Hospitalier Universitaire de Bordeaux Centre National de la Recherche Scientifique Université de Bordeaux Hôpital Saint-Louis

About

C Bilhou-Nabéra is an author at Hôpital Cardiologique du Haut-Lévêque specializing in cell biology, medicine, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	212
2	Cell Biology	5	5	118
3	Health Sciences	3	3	42
4	Cellular Therapies	2	2	23
5	Biomedical Engineering	1	1	11

C Bilhou-Nabéra

Publications

774

Citations

H-Index

Page 1

	Year	Citations
Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenstrom's macroglobulinemia Florence Nguyen‐Khac, Jérôme Lambert, Élise Chapiro, Haematologica	2012	141
Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: results of the GRAALL AFR09 study André Delannoy, Éric Delabesse, Véronique Lhéritier, Leukemia Hematological MalignancyOncologyElderly PatientsMixed-phenotype Acute LeukemiaPathology	2006	112
Autologous blood stem cell transplantation for chronic granulocytic leukaemia in transformation: a report of 47 cases Josy Reiffers, R. Trouette, Gérald Marit, British Journal of Haematology	1991	95
Follow-Up of Complete Cytogenetic Remission in Patients With Chronic Myeloid Leukemia After Cessation of Interferon Alfa F.-X. Mahon, X. Delbrel, Pascale Cony‐Makhoul, Journal of Clinical Oncology	2002	72
HIV Tat induces a prolonged MYC relocalization next to IGH in circulating B-cells Diego Germini, Tatyana Tsfasman, Manel Klibi, Leukemia Primary ImmunodeficiencyProlonged Myc RelocalizationViral PersistenceAutoimmune DiseaseHuman Retrovirus	2017	66
Response at Three Months Is a Good Predictive Factor for Newly Diagnosed Chronic Myeloid Leukemia Patients Treated by Recombinant Interferon- F.-X. Mahon, C. Fabères, Sophie Pueyo, Blood	1998	57
Response at Three Months Is a Good Predictive Factor for Newly Diagnosed Chronic Myeloid Leukemia Patients Treated by Recombinant Interferon- F.-X. Mahon, C. Fabères, Sophie Pueyo, Blood	1998	54
Treatment of Acute Lymphoblastic Leukemia in the Elderly: An Evaluation of Interferon Alpha Given as a Single Agent After Complete Remission André Delannoy, Bruno Cazin, Xavier Thomas, Leukemia & lymphoma/Leukemia and lymphoma	2002	29
Serial cytogenetic studies in allografted patients with chronic myeloid leukemia. C Bilhou-Nabéra, P Bernard, Gérald Marit, PubMed	1992	24
Response to recombinant interferon alpha in patients with chronic myelogenous leukemia in a single center: results and analysis of predictive factors. Marion Montastruc, Mahon Fx, C. Fabères, PubMed	1995	20

Page 1